help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattori, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hattori, N.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 586-590, Copyright © 1996 by Endocrine Society


ARTICLES

The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies

N Hattori
Department of Pharmacology, Kansai Medical University, Osaka, Japan.

We surveyed pregnant women for macroprolactinemia and examined the heterogeneity of its etiologies. Serum samples obtained from 105 pregnant women (29.7 +/- 4.4 yr) during the third trimester were treated with polyethylene glycol, and 3 women (2.9%) were found to have a significantly high proportion of precipitated prolactin (PRL). Gel filtration studies revealed that big-big PRL (molecular weight greater than 100,000) was predominant (63.6, 74.0, 43.5% vs. 0.3 +/- 0.2% in normal pregnant women). The common clinical features of the 3 women included idiopathic hyperprolactinemia without any clinical symptoms such as amenorrhea and galactorrhea before pregnancy and very high levels of PRL (1680, 793, and 790 micrograms/L vs. 315 +/- 112 micrograms/L in normal pregnant women) during pregnancy. However, the nature of big-big PRL was different. Two of the 3 women possessed anti- PRL autoantibody (125I-PRL binding to the serum: 17.6%, 18.6% vs. 6.9 +/- 1.6% in normal pregnant women), but the other one did not have it. A significantly high proportion of PRL was absorbed to a concanavalin A column (41.1% vs. 4.0 +/- 2.1% in normal pregnant women), repetitive freezing and thawing of isolated big-big PRL resulted in a partial conversion to big and little PRL, and reduction of the isolated big-big PRL with 2-mercaptoethanol almost completely converted big-big PRL to little PRL in this woman. These findings suggest that this woman had a heterogeneous complex of covalently and noncovalently bound form of PRL with increased glycosylation. We conclude that macroprolactinemia is present with considerable frequency in pregnant women and that different etiologies are involved to form big-big PRL in macroprolactinemia.


This article has been cited by other articles:


Home page
LupusHome page
A. Leanos-Miranda, G. Cardenas-Mondragon, A. Ulloa-Aguirre, I. Isordia-Salas, A. Parra, and J. Ramirez-Peredo
Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome
Lupus, May 1, 2007; 16(5): 342 - 349.
[Abstract] [PDF]


Home page
EndocrinologyHome page
N. Hattori, Y. Nakayama, K. Kitagawa, T. Li, and C. Inagaki
Development of Anti-PRL (Prolactin) Autoantibodies by Homologous PRL in Rats: A Model for Macroprolactinemia
Endocrinology, May 1, 2007; 148(5): 2465 - 2470.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
N Hattori, Y Nakayama, K Kitagawa, T Ishihara, Y Saiki, and C Inagaki
Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia.
J. Endocrinol., August 1, 2006; 190(2): 287 - 293.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Schiettecatte, A. Van Opdenbosch, E. Anckaert, J. De Schepper, K. Poppe, B. Velkeniers, and J. Smitz
Immunoprecipitation for Rapid Detection of Macroprolactin in the Form of Prolactin-Immunoglobulin Complexes
Clin. Chem., September 1, 2005; 51(9): 1746 - 1748.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Gibney, T. P. Smith, and T. J. McKenna
The Impact on Clinical Practice of Routine Screening for Macroprolactin
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3927 - 3932.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Hattori, K. Ikekubo, Y. Nakaya, K. Kitagawa, and C. Inagaki
Immunoglobulin G Subclasses and Prolactin (PRL) Isoforms in Macroprolactinemia Due to Anti-PRL Autoantibodies
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3036 - 3044.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Fahie-Wilson
In Hyperprolactinemia, Testing for Macroprolactin Is Essential
Clin. Chem., September 1, 2003; 49(9): 1434 - 1436.
[Full Text] [PDF]


Home page
Hum ReprodHome page
C. Mounier, J. Trouillas, B. Claustrat, R. Duthel, and B. Estour
Macroprolactinaemia associated with prolactin adenoma
Hum. Reprod., April 1, 2003; 18(4): 853 - 857.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Sapin and G. Kertesz
Macroprolactin Detection by Precipitation with Protein A-Sepharose: A Rapid Screening Method Compared with Polyethylene Glycol Precipitation
Clin. Chem., March 1, 2003; 49(3): 502 - 505.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Vallette-Kasic, I. Morange-Ramos, A. Selim, G. Gunz, S. Morange, A. Enjalbert, P.-M. Martin, P. Jaquet, and T. Brue
Macroprolactinemia Revisited: A Study on 106 Patients
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Leanos-Miranda, D. Pascoe-Lira, K. A. Chavez-Rueda, and F. Blanco-Favela
Persistence of Macroprolactinemia Due to Antiprolactin Autoantibody before, during, and after Pregnancy in a Woman with Systemic Lupus Erythematosus
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2619 - 2624.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Leslie, C. H. Courtney, P. M. Bell, D. R. Hadden, D. R. McCance, P. K. Ellis, B. Sheridan, and A. B. Atkinson
Laboratory and Clinical Experience in 55 Patients with Macroprolactinemia Identified by a Simple Polyethylene Glycol Precipitation Method
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2743 - 2746.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Pascoe-Lira, G. Duran-Reyes, I. Contreras-Hernández, L. Manuel-Apolinar, F. Blanco-Favela, and A. Leaños-Miranda
Frequency of Macroprolactinemia Due to Autoantibodies against Prolactin in Pregnant Women
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 924 - 929.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
M. J. Diver, D. L. Ewins, R. C. Worth, S. Bowles, J. A. Ahlquist, and M. N. Fahie-Wilson
An Unusual Form of Big, Big (Macro) Prolactin in a Pregnant Patient
Clin. Chem., February 1, 2001; 47(2): 346 - 348.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. N. Fahie-Wilson and R. John
Detection of Macroprolactin Causing Hyperprolactinemia in Commercial Assays for Prolactin Dr. John responds:
Clin. Chem., December 1, 2000; 46(12): 2022 - 2023.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Hattori and C. Inagaki
Anti-Prolactin (PRL) Autoantibodies Cause Asymptomatic Hyperprolactinemia: Bioassay and Clearance Studies of PRL-Immunoglobulin G Complex
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3107 - 3110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society